Publication: The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer.
dc.contributor.author | USTAALIOĞLU, BB | |
dc.contributor.author | BILICI, A | |
dc.contributor.author | ERCAN, S | |
dc.contributor.author | Seker, MESUT | |
dc.contributor.author | ORCUN, A | |
dc.contributor.author | GUMUS, M | |
dc.contributor.institutionauthor | ŞEKER, MESUT | |
dc.date.accessioned | 2020-10-29T22:17:31Z | |
dc.date.available | 2020-10-29T22:17:31Z | |
dc.date.issued | 2013-06-01T00:00:00Z | |
dc.identifier.citation | USTAALIOĞLU B., BILICI A., ERCAN S., Seker M., ORCUN A., GUMUS M., -The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer.-, Medical oncology (Northwood, London, England), cilt.30, ss.551, 2013 | |
dc.identifier.doi | 10.1007/s12032-013-0551-6 | |
dc.identifier.scopus | 84875343575 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12645/26521 | |
dc.identifier.wos | WOS:000319450400059 | |
dc.title | The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer. | |
dc.type | Article | |
dspace.entity.type | Publication | |
local.avesis.id | ab112cab-8f29-4c7c-af56-f45c4d5949dc | |
local.indexed.at | WOS | |
local.indexed.at | Scopus | |
local.publication.goal | 03 - Sağlık ve Kaliteli Yaşam | |
local.publication.isinternational | 1 | |
relation.isAuthorOfPublication | 8a03684e-e421-4a9f-9069-168fc121a5d4 | |
relation.isAuthorOfPublication.latestForDiscovery | 8a03684e-e421-4a9f-9069-168fc121a5d4 | |
relation.isGoalOfPublication | 9c198c48-b603-4e2f-8366-04edcfc1224c | |
relation.isGoalOfPublication.latestForDiscovery | 9c198c48-b603-4e2f-8366-04edcfc1224c |